---
figid: PMC7102917__OTT-13-2433-g0002
figtitle: ' Major downstream signaling pathways in GISTs'
organisms:
- NA
pmcid: PMC7102917
filename: OTT-13-2433-g0002.jpg
figlink: pmc/articles/PMC7102917/figure/F0002/
number: F2
caption: '(A) Major downstream signaling pathways in GISTs. Mutations in KIT/PDGFRA
  cause receptors to homodimerize on the cell surface and activate the tyrosine kinase
  domain which phosphorylates the tyrosine residue by transfer phosphate (P), activates
  the downstream signal pathway and then promotes the occurrence and development of
  GIST. (B) Tyrosine kinase inhibitor (TKI) blocks phosphorylation of downstream pathways
  and inhibits the progression of GIST by competitively binding KIT/PDGFRA with ATP.Abbreviations:
  PI3K, phosphoinositide 3-kinase; AKT, protein kinase B; mTOR, mammalian target of
  rapamycin; RAF, RAF proto-oncogene serine/threonine-protein kinase; MEK, mitogen-activated
  protein kinase; MAPK, mitogen-activated protein kinase; JAK2, Janus kinase 2; STAT3,
  signal transducer and activator of transcription 3.'
papertitle: The Use of Molecular Subtypes for Precision Therapy of Recurrent and Metastatic
  Gastrointestinal Stromal Tumor.
reftext: Peng Liu, et al. Onco Targets Ther. 2020;13:2433-2447.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9654796
figid_alias: PMC7102917__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7102917__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7102917__OTT-13-2433-g0002.html
  '@type': Dataset
  description: '(A) Major downstream signaling pathways in GISTs. Mutations in KIT/PDGFRA
    cause receptors to homodimerize on the cell surface and activate the tyrosine
    kinase domain which phosphorylates the tyrosine residue by transfer phosphate
    (P), activates the downstream signal pathway and then promotes the occurrence
    and development of GIST. (B) Tyrosine kinase inhibitor (TKI) blocks phosphorylation
    of downstream pathways and inhibits the progression of GIST by competitively binding
    KIT/PDGFRA with ATP.Abbreviations: PI3K, phosphoinositide 3-kinase; AKT, protein
    kinase B; mTOR, mammalian target of rapamycin; RAF, RAF proto-oncogene serine/threonine-protein
    kinase; MEK, mitogen-activated protein kinase; MAPK, mitogen-activated protein
    kinase; JAK2, Janus kinase 2; STAT3, signal transducer and activator of transcription
    3.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFRA
  - KIT
  - ATP8A2
  - WDTC1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - JAK2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MTOR
  - STAT3
  - ATP
  - ADP
---
